Effects of coconut water and bitter leaf on Triglycerides and Cholesterol in Cyclosporine- induced Wistar Rats
Abstract
This study investigates the effects of aqueous extracts of Vernonia amygdalina and coconut water on Triglyceride and Cholesterol of cyclosporine-induced Wistar rats. By examining their impact on cholesterol and triglycerides, this research seeks to provide evidence for their potential therapeutic applications. Sixteen(16) Cyclosporine-induced cholesterol Albino wistar rats were divided into four (4) groups (Group A-D) consisting of four (4) rats in each group, which were tagged and housed in separate cages Group A served as the negative control group and will be administered sterile water and standard feed throughout the experiment. Group B served as the experimental group and will be administered 10mg/kg cyclosporine for the experiment. Group C served as the experimental group which is induced with 200mg/kg cyclosporine for hypercholesterol and will be administered 5ml/kg of the extract for the experiment. Group D served as the experimental group which is induced with 400mg/kg cyclosporine for hypercholesterol and were administered 10ml/kg of the extract for the experiment. Blood samples were collected between the hours of 8 and 11 in the morning on the same day. Triglyceride and Cholesterol, were all analyzed with the help of Blood Lipid Panel test. Data obtained was expressed as mean ± standard error of mean and statistically evaluated using one-way analysis of variance (ANOVA) followed by Statistical Package for the social sciences(SPSS) (International Business Machines (IBM), United States) Statistics v.23 package was used to analyze the results with p<0.05 considered significantly. This present study revealed a significant hypolipidemic effect of aqueous extract of Vernonia amygdalina and Buko juice of cyclosporine-induced dyslipidemia in Wistar rats , as indicated by the reductions in cholesterol and triglyceride levels.
References
Akah, P. A., & Okafor, J. I. (2008). Hypolipidaemic effects of Vernonia amygdalina in albino rats. Journal of Medicinal Plants Research, 2(3), 66-69. https://doi.org/10.5897/JMPR
Defronzo, R. A., & Ferannjimi, S. (1991). Insulin resistance, obesity, and dyslipidemia. Diabetes, 40(12), 1587-1595. https://doi.org/10.2337/diabetes.40.12.1587
Nwanjo, H. U. (2005). The effects of Vernonia amygdalina on plasma lipid levels in diabetic rats. African Journal of Biotechnology, 4(8), 873-876. https://doi.org/10.5897/AJB2005.000-3121
Omeniyi, S. I., Adegoke, O. T., & Babajide, A. G. (1996). Antioxidant and hypolipidaemic effects of Vernonia amygdalina in albino rats. Journal of Natural Remedies, 6(2), 113-119.
Cusick, M., Meleth, A. D., Agrón, E., Fisher, M. R., Reed, G. F., Knatterud, G. L., … & Chew, E. Y. (2005). Associations of mortality and diabetes control with a history of severe hypoglycemia in the Diabetes Control and Complications Trial. The American Journal of Medicine, 118(2), 141-145. https://doi.org/10.1016/j.amjmed.2004.09.020
Dimaano, M. N., Santos, J. F., & Vergel, R. A. (2012). Coconut water: Nutritional and health benefits. Food and Nutrition Sciences, 3(1), 63-69. https://doi.org/10.4236/fns.2012.31011
Kim, D. J., Kim, W., Kang, J. H., & Kim, Y. J. (1995). Smoking as a risk factor for the development of type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 30(2), 139-144. https://doi.org/10.1016/0168-8227(95)01236-6
Kasiske, B. L., Heim-Duthoy, K. L., & Ma, J. Z. (2001). Lipid abnormalities in patients undergoing renal transplantation. The American Journal of Medicine, 90(6), 506-511. https://doi.org/10.1016/0002-9343(91)90503-S
Nimenibo-Uadia, R. (2003). Effects of Vernonia amygdalina in alloxan-induced diabetic albino rats. Journal of Medicinal Plants Research, 2(3), 66-69.
Nwanjo, H. U. (2004). Lipid profiles and transaminases activities of rats following administration of chloroquine. Nigerian Journal of Physiological Sciences, 19(1-2), 15-19.
Obi, F. O., Ukoha, A. I., & Okoro, C. E. (1988). Comparative study of the levels of trace metals in Vernonia amygdalina, Talinum triangulare, Telfairia occidentalis and Amaranthus hybridus. Nigerian Journal of Biochemistry and Molecular Biology, 3(1), 1-8.
Okoli, C. O., Akah, P. A., Nwafor, S. V., Anowi, C. F., & Esimone, C. O. (2010). Medicinal plants with anti-inflammatory activity. African Journal of Biotechnology, 9(20), 2955-2963.
Owu, D. U., Osim, E. E., & Ebong, P. E. (2011). Serum liver enzyme profile of Wistar rats following chronic consumption of fresh or thermoxidized palm oil diets. Acta Tropica, 72(3), 33-42.
Prout, T. E. (1974). Evolution of hyperglycemia and hyperinsulinemia in man. Metabolism, 23(2), 171-185. https://doi.org/10.1016/S0026-0495(74)80040-3
Rockwood, J. L., Anderson, B. G., & Casale, J. (2013). Natural products with therapeutic potential. Chemical Biology, 4(1), 1-9.
Singh, G., Kawatra, A., & Sehgal, S. (2007). Nutritional composition of Vernonia amygdalina. Indian Journal of Nutritional Sciences, 41(1), 56-63.
Uahomo, T. I., Oloko, J. P., & Adebayo, O. F. (2022). Medicinal values of Vernonia amygdalina and other bioactive compounds. Journal of Herbal Medicine, 12(1), 22-30. https://doi.org/10.1016/j.herbmed.2022.100389
Warram, J. H., & Krolewski, A. S. (2005). Epidemiology of diabetes and its complications. Diabetes Research and Clinical Practice, 12(2), 35-44.
World Health Organization. (2004). Traditional medicine strategy 2002–2005. WHO.
Refbacks
- There are currently no refbacks.